RetinalGenix Technologies Inc. financial data

Symbol
RTGN on OTC
Location
1450 North Mcdowell Boulevard, Suite 150, Petaluma, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 15, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity -103 % -2.05%
Return On Equity 163 % -36.9%
Return On Assets -5.45K % +80.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18.5M shares +4.14%
Common Stock, Shares, Outstanding 18.5M shares +3.71%
Entity Public Float 15.5M USD 0%
Common Stock, Value, Issued 1.85K USD +3.7%
Weighted Average Number of Shares Outstanding, Basic 18.5M shares +4.81%
Weighted Average Number of Shares Outstanding, Diluted 18.5M shares +4.81%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 13.2K USD -84.1%
General and Administrative Expense 1.35M USD +31.4%
Net Income (Loss) Attributable to Parent -2.76M USD +25.9%
Earnings Per Share, Basic 0 USD/shares +28.6%
Earnings Per Share, Diluted 0 USD/shares +28.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 44 USD -98.8%
Assets, Current 3.71K USD -92.6%
Property, Plant and Equipment, Net 31 USD -76.3%
Operating Lease, Right-of-Use Asset 6.19K USD
Assets 11.9K USD -76.4%
Liabilities, Current 1.67M USD
Operating Lease, Liability, Noncurrent 6.39K USD
Liabilities 1.68M USD +7.04%
Retained Earnings (Accumulated Deficit) -16M USD -20.8%
Stockholders' Equity Attributable to Parent -1.67M USD -9.82%
Liabilities and Equity 11.9K USD -76.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -187K USD -14.3%
Net Cash Provided by (Used in) Financing Activities 185K USD -13.7%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 18.5M shares +3.71%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.35K USD -105%
Deferred Tax Assets, Valuation Allowance 4.61M USD +39.1%
Deferred Tax Assets, Gross 4.61M USD +39.1%
Operating Lease, Liability 7.38K USD
Depreciation 25 USD 0%
Lessee, Operating Lease, Liability, to be Paid 19.6K USD
Operating Lease, Liability, Current 988 USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.52K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 8.11K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.2K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.52K USD
Deferred Tax Assets, Operating Loss Carryforwards 1.77M USD +23.3%
Preferred Stock, Shares Authorized 40M shares 0%
Operating Lease, Payments 7.69K USD
Additional Paid in Capital 14.3M USD +22.3%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 3.84K USD -17.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%